Copyright
©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Jan 15, 2026; 17(1): 114618
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.114618
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.114618
Right ventricular dysfunction in type 1 diabetic cardiomyopathy: An overlooked component?
Ling-Yun Luo, Zi-Xuan Liu, Tian-Shu Yang, Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China
Wei Liang, Xue-Lian Luo, Department of Oncology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China
Co-first authors: Ling-Yun Luo and Zi-Xuan Liu.
Co-corresponding authors: Wei Liang and Xue-Lian Luo.
Author contributions: Luo XL and Liang W contribute to the conception and design of the work as co-corresponding authors; Luo LY and Liu ZX have drafted the work as co-first authors; Yang TS and Luo XL substantively revised it. All authors have approved the submitted version.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xue-Lian Luo, MD, PhD, Department of Oncology, The Third Affiliated Hospital of Chongqing Medical University, Huixing Street, Yubei District, Chongqing 401120, China. 806850653@qq.com
Received: September 24, 2025
Revised: November 8, 2025
Accepted: December 3, 2025
Published online: January 15, 2026
Processing time: 112 Days and 10.6 Hours
Revised: November 8, 2025
Accepted: December 3, 2025
Published online: January 15, 2026
Processing time: 112 Days and 10.6 Hours
Core Tip
Core Tip: In type 1 diabetic cardiomyopathy, right ventricular (RV) function is a key determinant of patient prognosis and must not be neglected. RV performance should be incorporated into the inclusion criteria and endpoint selection of clinical trials. There is a critical need for more robust surrogate markers to evaluate RV-pulmonary arterial coupling. Additionally, the development of therapies that directly improve RV systolic and diastolic function is urgently required.